033270.KS
Korea United Pharm Inc. [033270.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
033270.KS Stock Summary
Top 10 Correlated Stocks
033270.KS
In the News
033270.KS Financial details
Company Rating
-
Market Cap
342.63B
Income
48.26B
Revenue
278.94B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
9.57
Forward P/E
-
PEG
15.45
P/S
1.47
P/B
1.04
P/C
-
P/FCF
10.67
Quick Ratio
-
Current Ratio
3.33
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
3.25K
EPS next Y
-
EPS next Q
-
EPS this Y
7.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
9.58%
Revenue last 5Y
4.74%
Revenue Q/Q
0.54%
EPS Q/Q
-84.63%
-
-
-
-
SMA20
0.75%
SMA50
6.29%
SMA100
14.28%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
12%
ROC
0.11%
Gross Margin
57%
Oper. Margin
15%
Profit Margin
15%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
20900.0-30600.0
52W High
-31.21%
52W Low
+0.72%
RSI
55.54
Rel Volume
1.11
Avg Volume
37.87K
Volume
42.07K
Perf Week
-0.47%
Perf Month
6.91%
Perf Quarter
13.29%
Perf Half Y
15.6%
-
-
-
-
Beta
0.418
-
-
Volatility
347.29%, 467.86%
Prev Close
-0.71%
Price
21050
Change
-0.47%
Company Profile
- Volume Average 37.87K
- Market Capitalization 342.63B
- CEO Mr. Duk-Young Kang
- Headquarters Seoul,KR
- IPO Date 2000-02-11
-
Website
https://www.kup.co.kr 
Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.
